NBIX Neurocrine Biosciences PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: NBIX
- PE Ratio
As of May 13, 2025, the NBIX stock has a PE ratio of 38.57. The calculation is based on the latest EPS of $3.03 and the stock price of $116.87 per share. An increase of 5% has been observed in the PE ratio compared to its average of 36.7 of the last four quarters.
NBIX PE ratio history
The mean historical PE ratio of Neurocrine Biosciences over the last seven years is 177.43. The current 38.57 P/E ratio is 78% lower than the historical average. Looking back at the last seven years, NBIX's PE ratio peaked in the Sep 2018 quarter at 1,229.5, with a price of $122.95 and an EPS of $0.1. The Sep 2021 quarter marked the lowest point at 20.11, with a price of $95.91 and an EPS of $4.77.
Neurocrine Biosciences PE ratio by year
Maximum annual increase: 648% in 2012
Maximum annual decrease: -91.86% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 40.15 | -21.99% | $136.5 | $3.4 |
| 2023 | 51.47 | -30.62% | $131.76 | $2.56 |
| 2022 | 74.19 | -17.24% | $119.44 | $1.61 |
| 2021 | 89.65 | 309.73% | $85.17 | $0.95 |
| 2020 | 21.88 | -91.86% | $95.85 | $4.38 |
| 2019 | 268.73 | -13.45% | $107.49 | $0.4 |
| 2018 | 310.48 | N/A | $71.41 | $0.23 |
| 2017 | N/A | N/A | $77.59 | -$1.62 |
| 2016 | N/A | N/A | $38.7 | -$1.63 |
| 2015 | N/A | N/A | $56.57 | -$1.05 |
| 2014 | N/A | N/A | $22.34 | -$0.81 |
| 2013 | N/A | N/A | $9.34 | -$0.69 |
| 2012 | 93.5 | 648% | $7.48 | $0.08 |
| 2011 | 12.5 | N/A | $8.5 | $0.68 |
| 2010 | N/A | N/A | $7.64 | -$0.15 |
Neurocrine Biosciences PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 36.5 | -9.09% | $110.6 | $3.03 |
| Dec 2024 | 40.15 | 34.51% | $136.5 | $3.4 |
| Sep 2024 | 29.85 | -25.64% | $115.22 | $3.86 |
| Jun 2024 | 40.14 | 9.73% | $137.67 | $3.43 |
| Mar 2024 | 36.58 | -28.93% | $137.92 | $3.77 |
| Dec 2023 | 51.47 | -10.33% | $131.76 | $2.56 |
| Sep 2023 | 57.4 | 11.39% | $112.5 | $1.96 |
| Jun 2023 | 51.53 | -65.89% | $94.3 | $1.83 |
| Mar 2023 | 151.07 | 103.63% | $101.22 | $0.67 |
| Dec 2022 | 74.19 | -57.39% | $119.44 | $1.61 |
| Sep 2022 | 174.11 | -76.78% | $106.21 | $0.61 |
| Jun 2022 | 749.85 | 507.86% | $97.48 | $0.13 |
| Mar 2022 | 123.36 | 37.6% | $93.75 | $0.76 |
| Dec 2021 | 89.65 | 345.8% | $85.17 | $0.95 |
| Sep 2021 | 20.11 | -19.2% | $95.91 | $4.77 |
NBIX Price vs fair value
NBIX average PE ratio chart
NBIX's current PE ratio is lower than its 3, 5 and 10-year averages.
NBIX PE vs peers
In comparison to its peers LLY and ABBV, NBIX's PE ratio is lower, but it is higher than PFE's and RPRX's. Neurocrine Biosciences's PE ratio is trading below the peer average of 42.47.
| Stock name | PE ratio | Market cap |
|---|---|---|
| RPRX Royalty Pharma plc | 13.07 | $18.15B |
| PFE Pfizer Inc | 15.84 | $125.19B |
| NBIX Neurocrine Biosciences Inc | 39.2 | $11.76B |
| LLY ELI LILLY & Co | 57.99 | $678.16B |
| ABBV AbbVie Inc | 75.19 | $313.43B |
| RGEN Repligen Corp | N/A | $7.19B |
| ANIP Ani Pharmaceuticals Inc | N/A | $1.31B |
| CASI CASI Pharmaceuticals Inc | N/A | $29.59M |
Frequently asked questions
What is Neurocrine Biosciences's PE ratio?
The price to earnings ratio for NBIX stock is 38.57 as of May 13, 2025.
What is the 3-year average PE ratio for Neurocrine Biosciences (NBIX)?
Over the last 3 years, the average price to earnings ratio for NBIX stock is 124.4.
What is the 5-year average PE ratio for Neurocrine Biosciences (NBIX)?
Over the last 5 years, the average price to earnings ratio for NBIX stock is 97.27.
What is the highest PE ratio for NBIX?
The highest quarterly PE ratio in the last seven years has been 1,229.5 and it was in the Sep 2018 quarter.
How does the current PE ratio for NBIX compare to its historical average?
NBIX's current price to earnings ratio is 78% below its 7-year historical average.
How is NBIX's PE ratio calculated (Neurocrine Biosciences PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (May 13, 2025), Neurocrine Biosciences's share price is $116.87. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $3.03. Therefore, Neurocrine Biosciences's PE ratio for today is 38.57. PE RATIO(38.57) = STOCK PRICE($116.87) / TTM EPS($3.03)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.